8601 - 8650 of 9145 Results
Title
Year
-
OPENTitle: Pandemic Tic‐like Behaviors Following Social Media ConsumptionJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2932End Page: 2935Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28800Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28800Citation Count: 74
- Screening of GBA Mutations in Nigerian Patients with Parkinson's Disease2021RESTRICTEDTitle: Screening of GBA Mutations in Nigerian Patients with Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2971End Page: 2973Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28803Citation Count: 9
- Early‐Onset Parkinson's Disease: A Novel Deletion Comprising the DJ‐1 and TNFRSF9 Genes2021RESTRICTEDTitle: Early‐Onset Parkinson's Disease: A Novel Deletion Comprising the DJ‐1 and TNFRSF9 GenesJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2973End Page: 2976Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28812Citation Count: 16
- Moving From Wired to Wireless Brain Stimulation to Treat Movement Disorders: Are We Breaking Ground?2021RESTRICTEDTitle: Moving From Wired to Wireless Brain Stimulation to Treat Movement Disorders: Are We Breaking Ground?Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 3Start Page: 610End Page: 610Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28499Citation Count: 0
-
OPENTitle: Reply to: “Cell Therapy for Huntington's Disease: Learning from Failure”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 3Start Page: 788End Page: 789Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28500Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28500Citation Count: 1
-
OPENTitle: Non‐Motor Fluctuations in Parkinson's Disease: Validation of the Non‐Motor Fluctuation Assessment QuestionnaireJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1392End Page: 1400Publication Date:Open Access(OA) Status: OPENLicense: public-domainDOI - Digital Object Identifier: 10.1002/mds.28507Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28507Citation Count: 47
-
OPENTitle: A Novel SNCA A30G Mutation Causes Familial Parkinsonʼs DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1624End Page: 1633Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.28534Best OA location URL: https://pub.dzne.de/record/155632Citation Count: 114
- Parkinson's Kinesia Paradoxa Is Not a Paradox2021OPENTitle: Parkinson's Kinesia Paradoxa Is Not a ParadoxJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 5Start Page: 1115End Page: 1118Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28550Citation Count: 34
- Innovating Parkinson's Care: A Randomized Controlled Trial of Telemedicine Depression Treatment2021OPENTitle: Innovating Parkinson's Care: A Randomized Controlled Trial of Telemedicine Depression TreatmentJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2549End Page: 2558Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28548Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11822725Citation Count: 49
-
OPENTitle: Changes in Body Composition Before and After Parkinson's Disease DiagnosisJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1617End Page: 1623Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28536Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10775470/pdf/nihms-1945637.pdfCitation Count: 23
-
OPENTitle: Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA‐FLUO TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1704End Page: 1711Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28569Best OA location URL: https://hal.science/hal-03190779Citation Count: 25
- Phenoconversion from Possible REM Sleep Behavior to Parkinsonism in the Population‐Based CLSA2021RESTRICTEDTitle: Phenoconversion from Possible REM Sleep Behavior to Parkinsonism in the Population‐Based CLSAJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1466End Page: 1467Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28571Citation Count: 6
- A New Approach to the Development of Disease‐Modifying Therapies for PD2021RESTRICTEDTitle: A New Approach to the Development of Disease‐Modifying Therapies for PDJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 5Start Page: 1281End Page: 1281Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28589Citation Count: 1
-
OPENTitle: Corneal Confocal Microscopy Identifies Parkinson's Disease with More Rapid Motor ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1927End Page: 1934Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.28602Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28602Citation Count: 30
- Reply to: “A New Approach to the Development of Disease‐Modifying Therapies for PD”2021RESTRICTEDTitle: Reply to: “A New Approach to the Development of Disease‐Modifying Therapies for PD”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 5Start Page: 1281End Page: 1282Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28588Citation Count: 0
- Cerebrospinal α‐Synuclein Oligomers Reflect Disease Motor Severity in DeNoPa Longitudinal Cohort2021OPENTitle: Cerebrospinal α‐Synuclein Oligomers Reflect Disease Motor Severity in DeNoPa Longitudinal CohortJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 9Start Page: 2048End Page: 2056Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28611Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28611Citation Count: 43
-
OPENTitle: Scoring Algorithm‐Based Genomic Testing in Dystonia: A Prospective Validation StudyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1959End Page: 1964Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28614Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28614Citation Count: 27
- Beyond Just Connectivity — Neuronal Activity Drives α‐Synuclein Pathology2021RESTRICTEDTitle: Beyond Just Connectivity — Neuronal Activity Drives α‐Synuclein PathologyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1487End Page: 1488Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28618Citation Count: 6
- Reply to: “Increased alpha‐Synuclein Level in CD45+ Blood Cells in Asymptomatic Carriers of GBA Mutations”2021RESTRICTEDTitle: Reply to: “Increased alpha‐Synuclein Level in CD45+ Blood Cells in Asymptomatic Carriers of GBA Mutations”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1998End Page: 1999Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28678Citation Count: 0
-
OPENTitle: Multimodal Longitudinal Neurophysiological Investigations in Dopa‐Responsive DystoniaJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1986End Page: 1987Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28679Best OA location URL: https://doi.org/10.1002/mds.28679Citation Count: 6
-
OPENTitle: Home-based transcranial static magnetic field stimulation of the motor cortex for treating levodopa-induced dyskinesias in Parkinson's disease: A randomized controlled trialJournal Name: Brain StimulationPublisher: Elsevier BVVol: 15Issue #: 3Start Page: 857End Page: 860Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.brs.2022.05.012Best OA location URL: http://www.brainstimjrnl.com/article/S1935861X22000912/pdfCitation Count: 24
-
OPENTitle: Analysis of voice as an assisting tool for detection of Parkinson's disease and its subsequent clinical interpretationJournal Name: Biomedical Signal Processing and ControlPublisher: Elsevier BVVol: 66Issue #:Start Page: 102415End Page: 102415Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.bspc.2021.102415Best OA location URL: https://doi.org/10.1016/j.bspc.2021.102415Citation Count: 65
-
OPENTitle: Emotions Modulate Subthalamic Nucleus Activity: New Evidence in Obsessive-Compulsive Disorder and Parkinson’s Disease PatientsJournal Name: Biological Psychiatry: Cognitive Neuroscience and NeuroimagingPublisher: Elsevier BVVol: 6Issue #: 5Start Page: 556End Page: 567Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bpsc.2020.08.002Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S2451902220302123?via%3DihubCitation Count: 18
-
OPENTitle: Pharmacological inhibition of AIMP2 aggregation attenuates α-synuclein aggregation and toxicity in Parkinson’s diseaseJournal Name: Biomedicine & PharmacotherapyPublisher: Elsevier BVVol: 156Issue #:Start Page: 113908End Page: 113908Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.biopha.2022.113908Best OA location URL: https://doi.org/10.1016/j.biopha.2022.113908Citation Count: 7
-
OPENTitle: Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson’s disease and cognitionJournal Name: Brain, Behavior, and ImmunityPublisher: Elsevier BVVol: 101Issue #:Start Page: 182End Page: 193Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.bbi.2022.01.005Best OA location URL: https://doi.org/10.1016/j.bbi.2022.01.005Citation Count: 56
- Lifetime neuropsychiatric symptoms in Huntington's disease: Implications for psychiatric nursing2021RESTRICTEDTitle: Lifetime neuropsychiatric symptoms in Huntington's disease: Implications for psychiatric nursingJournal Name: Archives of Psychiatric NursingPublisher: Elsevier BVVol: 35Issue #: 3Start Page: 284End Page: 289Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.apnu.2021.03.006Citation Count: 8
- A conversation with Judith Campisi: Leader in the field of aging research2021OPENTitle: A conversation with Judith Campisi: Leader in the field of aging researchJournal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 69Issue #:Start Page: 101366End Page: 101366Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.arr.2021.101366Citation Count: 2
-
OPENTitle: Data imputation and compression for Parkinson's disease clinical questionnairesJournal Name: Artificial Intelligence in MedicinePublisher: Elsevier BVVol: 114Issue #:Start Page: 102051End Page: 102051Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.artmed.2021.102051Best OA location URL: https://hal.science/hal-02570967/documentCitation Count: 30
-
OPENTitle: Subtle anomaly detection: Application to brain MRI analysis of de novo Parkinsonian patientsJournal Name: Artificial Intelligence in MedicinePublisher: Elsevier BVVol: 125Issue #:Start Page: 102251End Page: 102251Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.artmed.2022.102251Best OA location URL: https://doi.org/10.1016/j.artmed.2022.102251Citation Count: 15
- A high dose tango intervention for people with Parkinson's disease (PwPD)2021RESTRICTEDTitle: A high dose tango intervention for people with Parkinson's disease (PwPD)Journal Name: Advances in Integrative MedicinePublisher: Elsevier BVVol: 8Issue #: 4Start Page: 272End Page: 277Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.aimed.2021.07.005Citation Count: 6
- In-Home Falls Risk Assessment in Parkinson Disease: A Guide for Clinicians2021OPENTitle: In-Home Falls Risk Assessment in Parkinson Disease: A Guide for CliniciansJournal Name: Archives of Physical Medicine and RehabilitationPublisher: Elsevier BVVol: 102Issue #: 10Start Page: 2051End Page: 2054Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.apmr.2021.04.001Citation Count: 3
- Slowing Parkinson’s Disease Progression with Vaccination and Other Immunotherapies2022RESTRICTEDTitle: Slowing Parkinson’s Disease Progression with Vaccination and Other ImmunotherapiesJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 36Issue #: 4Start Page: 327End Page: 343Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40263-022-00903-7Citation Count: 8
- The protean roles of neuroinflammation in trauma, infections, autoimmunity and neurodegeneration2022RESTRICTEDTitle: The protean roles of neuroinflammation in trauma, infections, autoimmunity and neurodegenerationJournal Name: Seminars in ImmunologyPublisher: Elsevier BVVol: 61-64Issue #:Start Page: 101655End Page: 101655Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.smim.2022.101655Citation Count: 3
-
OPENTitle: Improving domain definition and outcome instrument selection: Lessons learned for OMERACT from imagingJournal Name: Seminars in Arthritis and RheumatismPublisher: Elsevier BVVol: 51Issue #: 5Start Page: 1125End Page: 1133Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.semarthrit.2021.08.004Best OA location URL: https://research.vumc.nl/en/publications/d083f460-428b-4cc9-b64c-8e646fc9a1c6Citation Count: 29
-
OPENTitle: An economic evaluation of the NightWatch for children with refractory epilepsy: Insight into the cost-effectiveness and cost-utilityJournal Name: Seizure: European Journal of EpilepsyPublisher: Elsevier BVVol: 101Issue #:Start Page: 156End Page: 161Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.seizure.2022.08.003Best OA location URL: http://www.seizure-journal.com/article/S1059131122001820/pdfCitation Count: 11
-
OPENTitle: How firms undertake organizational changes to shift to more-exploratory strategies: A process perspectiveJournal Name: Research PolicyPublisher: Elsevier BVVol: 50Issue #: 1Start Page: 104118End Page: 104118Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.respol.2020.104118Best OA location URL: https://minesparis-psl.hal.science/hal-02943926Citation Count: 28
- Serial olfactory testing for the diagnosis of prodromal Parkinson's disease in the PARS study2022RESTRICTEDTitle: Serial olfactory testing for the diagnosis of prodromal Parkinson's disease in the PARS studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 104Issue #:Start Page: 15End Page: 20Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.09.007Citation Count: 11
- The effect of limb selection methods on gait analysis in Parkinson's disease2022RESTRICTEDTitle: The effect of limb selection methods on gait analysis in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 104Issue #:Start Page: 81End Page: 84Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.013Citation Count: 2
-
OPENTitle: Characterization and diagnostic potential of R2* in early-stage progressive supranuclear palsy variantsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 43End Page: 48Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.021Best OA location URL: http://www.prd-journal.com/article/S1353802022002176/pdfCitation Count: 11
- The plight of loneliness in Parkinson's disease: New opportunities2022RESTRICTEDTitle: The plight of loneliness in Parkinson's disease: New opportunitiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 105Issue #:Start Page: 145End Page: 148Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.029Citation Count: 7
-
OPENTitle: ND0612 (levodopa/carbidopa for subcutaneous infusion) in patients with Parkinson's disease and motor response fluctuations: A randomized, placebo-controlled phase 2 studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 91Issue #:Start Page: 139End Page: 145Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.09.024Best OA location URL: http://www.prd-journal.com/article/S1353802021003539/pdfCitation Count: 50
- Increased functional connectivity in a population at risk of developing Parkinson's disease2021RESTRICTEDTitle: Increased functional connectivity in a population at risk of developing Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 1End Page: 6Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.09.026Citation Count: 9
- Visual dysfunction is associated with cognitive impairment in Parkinson's disease2021RESTRICTEDTitle: Visual dysfunction is associated with cognitive impairment in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 22End Page: 25Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.005Citation Count: 16
- What the VaP? The meaning of “vascular parkinsonism”2021RESTRICTEDTitle: What the VaP? The meaning of “vascular parkinsonism”Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 94Issue #:Start Page: 132End Page: 134Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.12.008Citation Count: 10
-
OPENTitle: Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medicationsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 59End Page: 66Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.009Best OA location URL: http://www.prd-journal.com/article/S1353802021003643/pdfCitation Count: 57
- Predictors of multi-domain cognitive decline following DBS for treatment of Parkinson's disease2021RESTRICTEDTitle: Predictors of multi-domain cognitive decline following DBS for treatment of Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 95Issue #:Start Page: 23End Page: 27Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.12.011Citation Count: 15
-
OPENTitle: Stimulation of the pedunculopontine and cuneiform nuclei for freezing of gait and falls in Parkinson disease: Cross-over single-blinded study and long-term follow-upJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 96Issue #:Start Page: 13End Page: 17Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.01.010Best OA location URL: https://hal.sorbonne-universite.fr/hal-03603648Citation Count: 19
- Perivascular space in Parkinson's disease: Association with CSF amyloid/tau and cognitive decline2022RESTRICTEDTitle: Perivascular space in Parkinson's disease: Association with CSF amyloid/tau and cognitive declineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 95Issue #:Start Page: 70End Page: 76Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.01.002Citation Count: 41
-
OPENTitle: Necessity and feasibility of remote tele-programming of deep brain stimulation systems in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 96Issue #:Start Page: 38End Page: 42Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.01.017Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.01.017Citation Count: 32
-
RESTRICTEDTitle: Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 96Issue #:Start Page: 65End Page: 73Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.01.022Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.01.022Citation Count: 0